| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | isonicotinohydroxamic acid | CTRPv2 | pan-cancer | AAC | -0.049 | 0.3 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.047 | 0.3 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.3 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | 0.17 | 0.3 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | -0.034 | 0.3 |